Literature DB >> 22171590

Negative predictive value of skin tests to neuromuscular blocking agents.

L F Ramirez1, A Pereira, A M Chiriac, M-C Bonnet-Boyer, P Demoly.   

Abstract

Allergy to neuromuscular blocking agents (NMBAs) is the most important caue of perioperative anaphylaxis in France. The diagnosis relies on a careful clinical history, the search of serum IgE antibodies, and the realization of skin tests. Although the skin tests are the most important tool and their sensitivity is widely recognized, the lack of information about their negative predictive value represents an important issue in the management of patients who require a new procedure with NMBA injection. We present a series of 49 patients with confirmed allergy to NMBAs, six of whom required a subsequent surgery with neuromuscular blockade. Negative skin tests allowed the selection of an alternative NMBA, which was well tolerated in all 6 cases. We found an excellent negative predictive value of skin tests in our series but larger studies are required to properly address this question.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171590     DOI: 10.1111/j.1398-9995.2011.02753.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  3 in total

Review 1.  Pediatric Patients with Previous Anaphylactic Reactions to General Anesthesia: a Review of Literature, Case Report, and Anesthetic Considerations.

Authors:  Manjiao Ma; Bo Zhu; Jing Zhao; Hongyi Li; Lian Zhou; Mu Wang; Xiuhua Zhang; Yuguang Huang
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-22       Impact factor: 4.806

Review 2.  Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?

Authors:  David Spoerl; Haig Nigolian; Christoph Czarnetzki; Thomas Harr
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

3.  Skin Testing to Identify Safe Drugs for Patients with Rocuronium-Induced Anaphylaxis.

Authors:  Manzo Suzuki; Hajime Kawase; Azusa Ogita; Hiroyasu Bito
Journal:  Case Rep Anesthesiol       Date:  2020-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.